Spacetalk Ltd (ASX:SPA) Licenses Watch Walk AI for Health Risk Detection
Spacetalk Ltd (ASX:SPA) licenses Watch Walk AI to enhance health risk detection in its wearable devices.
Spacetalk Ltd (ASX:SPA) licenses Watch Walk AI to enhance health risk detection in its wearable devices.
Fisher & Paykel Healthcare (ASX:FPH) signs a $250M construction contract to expand its Auckland campus, enhancing capacity for future growth.
Wellnex Life Limited (ASX:WNX) raises $2.2 million through Entitlement Offer and moves forward with dual AIM listing.
Race Oncology (ASX:RAC) secures an $8.6m contract with George Clinical to advance Phase 1 trials of RC220 in solid tumour patients.
Oceania Healthcare (ASX:OCA) reports increased sales, successful $500m debt refinancing, and strategic business optimisations for FY25.
Oceania Healthcare (ASX:OCA) completes debt refinancing and reports a 29% increase in new sales volumes in its latest market update.
Invion Limited (ASX:IVX) successfully raises $2M through a share placement to fund its Phase I/II cancer clinical trials.
Biotron Limited (ASX:BIT) withdraws its Share Purchase Plan and announces a $750,000 Rights Issue with Mahe Capital to secure its financial position.
Imricor Medical Systems (ASX:IMR) submits its second FDA PMA module, advancing regulatory progress and preparing for upcoming product launches.
Firebrick Pharma (ASX:FRE) secures a $1.1 million strategic investment from Pharma Nutria N.A., Inc., strengthening its partnership in the Philippines.